Bottom line
Is CWVGX a good fund? The bottom line
CWVGX is the Class A share class of Calvert International Equity Fund, a managed international stock mutual fund from Morgan Stanley.
It charges 1.14% — about $114 a year on every $10,000 invested, more expensive than 71% of international stock funds we track.
It returned +13.0% over one year, +3.6% a year over five years (as of Dec 31, 2025, per its prospectus).
With $835 million in net assets and 45 holdings, its largest position is ASML Holding NV (5.7%) and the top 10 make up 37.4% of the portfolio.
This share class carries a front-end sales charge of up to 5.25%; a no-load class or ETF alternative can avoid it.
What to watch
- Expensive for its category (1.14%)
- 5-year return in the bottom quarter of its category
- Front-end sales load up to 5.25%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What CWVGX invests in
The Funds investment objective is to seek to provide high total return consistent with reasonable risk by investing primarily in a diversified portfolio of stocks.
The Fund normally invests at least 80% of its net assets, including borrowings for investment purposes, in equity securities of foreign companies (common and preferred stock and the depositary receipts on such stock) (the 80% Policy). Using a core investment approach, the Fund invests primarily in common and preferred stocks of non-U.S. large-cap companies. The Fund defines non-U.S. large-cap companies as those whose market capitalization falls within the range of the Morgan Stanley Capital International (MSCI) Europe, Australasia and Far East (EAFE) Index at the time of investment. As of December 31, 2025, the market capitalization of the MSCI EAFE companies ranged from $4.3 billion to $419.4 billion with a weighted average market capitalization of $105.6 billion. Market capitalizations of companies within the MSCI EAFE Index are subject to change. The Fund generally holds stocks of…
From the fund's prospectus (filed Jan 27, 2026).
CWVGX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| CWVGX | +13.0% | +3.6% | — |
| International Stock median | +25.5% | +6.4% | +7.6% |
Source: Fund prospectus, as of Dec 31, 2025
What CWVGX costs
On a $10,000 investment, CWVGX's 1.14% expense ratio costs about $114 a year. The prospectus estimates $1,908 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.
CWVGX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | ASML Holding NV | 5.71% |
| 2 | Nestle SA | 4.76% |
| 3 | AstraZeneca PLC | 4.03% |
| 4 | Compass Group PLC | 3.74% |
| 5 | Iberdrola SA | 3.32% |
| 6 | Roche Holding AG | 3.22% |
| 7 | Keyence Corp | 3.18% |
| 8 | Schneider Electric SE | 3.17% |
| 9 | AIA Group Ltd | 3.15% |
| 10 | BNP Paribas SA | 3.10% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 37.4% of the fund. See all top 25 holdings and asset mix →